Literature DB >> 28986887

Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres.

Pooja Mehta1, Caymen Novak2, Shreya Raghavan1, Maria Ward1, Geeta Mehta3,4,5.   

Abstract

Cancer stem cells (CSC) are a vital component to the progression and reoccurrence of cancers, making them a primary target of study for both fundamental understanding of cancer biology and the development of effective and targeted treatments. CSCs reside in a complex 3D microenvironment, and the 3D spheroids are an indispensable tool in tumor biology due to their 3D structure and replication of the tumor microenvironment. Within this chapter the methodology for CSC isolation, suspension culture in hanging drop model, and characterization assays for CSC are described. First, the methodology for identifying and isolating CSCs from patient tumors, ascites, or cancer cell lines is described through the use of FACS analysis. Next, a detailed description of 3D hanging drop model for generating CSC spheroids is provided, followed by maintenance and monitoring techniques for extended 3D culture. Analysis methods are described for the quantification of CSC spheroid proliferation and viability tracking, throughout culture by on-plate alamarBlue fluorescence. Additional viability assays are described utilizing confocal microscopy with Live/Dead Viability/Cytotoxicity Kit. The characterization of CSCs populations within spheroids is described through FACS analysis. Further, an immunohistochemistry procedure is described for cell-cell and cell-matrix interaction assessment. Finally, several notes and tips for successful experiments with 3D CSC spheroids on the hanging drop model are provided. These methods are not only applicable to CSCs within a variety of tumor cell types, for not only understanding the fundamental tumor biology, but also for drug screening and development of preclinical chemotherapeutic strategies.

Entities:  

Keywords:  Cancer stem cells; Drug sensitivity; Hanging drop; Ovarian cancer; Proliferation; Spheroid; Viability

Mesh:

Year:  2018        PMID: 28986887      PMCID: PMC5925737          DOI: 10.1007/978-1-4939-7401-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Cancer stem cells: nature versus nurture.

Authors:  Hasan Korkaya; Max S Wicha
Journal:  Nat Cell Biol       Date:  2010-04-25       Impact factor: 28.824

3.  The microwell-mesh: A novel device and protocol for the high throughput manufacturing of cartilage microtissues.

Authors:  Kathryn Futrega; James S Palmer; Mackenzie Kinney; William B Lott; Mark D Ungrin; Peter W Zandstra; Michael R Doran
Journal:  Biomaterials       Date:  2015-05-20       Impact factor: 12.479

4.  Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.

Authors:  Yoshinori Imamura; Toru Mukohara; Yohei Shimono; Yohei Funakoshi; Naoko Chayahara; Masanori Toyoda; Naomi Kiyota; Shintaro Takao; Seishi Kono; Tetsuya Nakatsura; Hironobu Minami
Journal:  Oncol Rep       Date:  2015-01-29       Impact factor: 3.906

Review 5.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

6.  High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array.

Authors:  Yi-Chung Tung; Amy Y Hsiao; Steven G Allen; Yu-suke Torisawa; Mitchell Ho; Shuichi Takayama
Journal:  Analyst       Date:  2010-10-21       Impact factor: 4.616

Review 7.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

8.  ATP citrate lyase knockdown impacts cancer stem cells in vitro.

Authors:  J-I Hanai; N Doro; P Seth; V P Sukhatme
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

9.  Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity.

Authors:  Shreya Raghavan; Pooja Mehta; Eric N Horst; Maria R Ward; Katelyn R Rowley; Geeta Mehta
Journal:  Oncotarget       Date:  2016-03-29

10.  Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme.

Authors:  Marju Kase; Ave Minajeva; Kristi Niinepuu; Sandra Kase; Markus Vardja; Toomas Asser; Jana Jaal
Journal:  Radiol Oncol       Date:  2013-10-08       Impact factor: 2.991

View more
  15 in total

1.  Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer.

Authors:  Jason R Brown; Daniel K Chan; Jessica J Shank; Kent A Griffith; Huihui Fan; Robert Szulawski; Kun Yang; R Kevin Reynolds; Carolyn Johnston; Karen McLean; Shitanshu Uppal; J Rebecca Liu; Lourdes Cabrera; Sarah E Taylor; Brian C Orr; Francesmary Modugno; Pooja Mehta; Michael Bregenzer; Geeta Mehta; Hui Shen; Lan G Coffman; Ronald J Buckanovich
Journal:  JCI Insight       Date:  2020-06-04

2.  The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods.

Authors:  Michael Bregenzer; Eric Horst; Pooja Mehta; Catherine Snyder; Taylor Repetto; Geeta Mehta
Journal:  Methods Mol Biol       Date:  2022

3.  Formoxanthone C Inhibits Malignant Tumor Phenotypes of Human A549 Multidrug Resistant-cancer Cells through Signal Transducer and Activator of Transcription 1-Histone Deacetylase 4 Signaling.

Authors:  Chutima Kaewpiboon; Young-Hwa Chung; Nawong Boonnak; Sirichat Kaowinn; Natpaphan Yawut
Journal:  J Cancer Prev       Date:  2022-06-30

4.  Novel Omniphobic Platform for Multicellular Spheroid Generation, Drug Screening, and On-Plate Analysis.

Authors:  Mathew Boban; Pooja Mehta; Alex Kate Halvey; Taylor Repetto; Anish Tuteja; Geeta Mehta
Journal:  Anal Chem       Date:  2021-05-26       Impact factor: 8.008

5.  Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance.

Authors:  Maria R Ward Rashidi; Pooja Mehta; Michael Bregenzer; Shreya Raghavan; Elyse M Fleck; Eric N Horst; Zainab Harissa; Visweswaran Ravikumar; Samuel Brady; Andrea Bild; Arvind Rao; Ronald J Buckanovich; Geeta Mehta
Journal:  Neoplasia       Date:  2019-07-09       Impact factor: 5.715

Review 6.  PI3K in stemness regulation: from development to cancer.

Authors:  Ralitsa R Madsen
Journal:  Biochem Soc Trans       Date:  2020-02-28       Impact factor: 5.407

7.  Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties.

Authors:  Valentina Pasquale; Giacomo Ducci; Gloria Campioni; Adria Ventrici; Chiara Assalini; Stefano Busti; Marco Vanoni; Riccardo Vago; Elena Sacco
Journal:  Cells       Date:  2020-12-11       Impact factor: 6.600

8.  A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis.

Authors:  Pawat Pattarawat; Jessica T Hunt; Jacob Poloway; Collin J Archibald; Hwa-Chain Robert Wang
Journal:  Cancer Chemother Pharmacol       Date:  2021-05-27       Impact factor: 3.288

9.  A novel model of liver cancer stem cells developed from induced pluripotent stem cells.

Authors:  Said M Afify; Anna Sanchez Calle; Ghmkin Hassan; Kazuki Kumon; Hend M Nawara; Maram H Zahra; Hager M Mansour; Apriliana Cahya Khayrani; Md Jahangir Alam; Juan Du; Akimasa Seno; Yoshiaki Iwasaki; Masaharu Seno
Journal:  Br J Cancer       Date:  2020-03-17       Impact factor: 7.640

10.  The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells.

Authors:  Chiara Bellio; Celeste DiGloria; David R Spriggs; Rosemary Foster; Whitfield B Growdon; Bo R Rueda
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.